Longevity Protocol with Chronic Kidney Disease

How CKD Accelerates Aging

The kidneys are not simply filters. They help regulate blood pressure, activate vitamin D, produce erythropoietin (the hormone that drives red blood cell production) and keep the body's acid-base and mineral balance steady. When kidney function declines, those systems drift, and the effects reach well beyond the kidneys.

For most people with CKD, the heart is at greater risk than the kidneys. Over five years of follow-up in a large managed-care organization, far more people with stage 2–4 CKD died than ever needed dialysis or a transplant.¹ Among more than a million adults in one US health system, the risk of a cardiovascular event rose steadily as kidney function fell: about 1.4 times the risk at an eGFR of 45–59, 2.0 times at 30–44 and 2.8 times at 15–29, compared with an eGFR of 60 or more.² Protein in the urine (albuminuria) adds risk of its own: across 14 general-population cohorts, a urine albumin-to-creatinine ratio of 10 mg/g or more predicted higher mortality independently of eGFR.³

Progression is not inevitable. In two large trials, an SGLT2 inhibitor lowered the risk of a combined outcome of serious kidney decline, kidney failure or cardiovascular death by 39 percent with dapagliflozin (DAPA-CKD) and by 28 percent with empagliflozin (EMPA-KIDNEY), with similar effects in people with and without diabetes.^4,5

Exercise with Kidney Disease

Exercise is underused in CKD. In a US national survey, 28 percent of adults with CKD were physically inactive, about twice the rate in adults without it, and inactivity was linked to higher mortality in both groups.⁶ KDIGO, the international kidney guideline group, recommends at least 150 minutes a week of moderate-intensity activity, or as much as your heart and physical tolerance allow.⁷ A Cochrane review of 45 trials found that regular exercise improved aerobic capacity, walking capacity, resting blood pressure and heart rate in people with CKD.⁸

Aerobic exercise, building toward 150 minutes a week — Start low and progress gradually. Many people with CKD have reduced exercise tolerance because of anemia and deconditioning, so walking is a sensible place to begin.

Resistance training (2–3 times a week) — CKD speeds muscle loss, and strength work pushes back. In a 12-week randomized trial in older adults with moderate CKD on a low-protein diet, resistance training enlarged muscle fibers and raised strength by about a third, while strength fell in the group that did not train.⁹ Use moderate loads with controlled movements, and avoid breath-holding (the Valsalva maneuver) if your blood pressure is not controlled.

Check potassium and fluid limits first. In advanced CKD, ask your nephrologist about potassium and any fluid restriction before starting a demanding program, and stay hydrated within those limits.

Nutrition: The CKD Balance

CKD nutrition balances two goals: enough protein to keep muscle, without the excess that adds strain to damaged kidneys. The right plan depends on your stage and your blood tests.

Protein: For adults with CKD stages G3–G5, KDIGO suggests about 0.8 g of protein per kilogram of body weight a day and advises avoiding high intakes above 1.3 g/kg a day when CKD may progress. For people at risk of kidney failure, a very-low-protein diet with supplements is an option only under close supervision. KDIGO also favors a varied diet with more plant-based than animal-based foods and fewer ultraprocessed foods.⁷

Sodium under 2 g a day — This is KDIGO's suggested limit for adults with CKD, equal to about 5 g of salt.⁷ Cutting salt also makes blood-pressure drugs work better: in a randomized trial in people with non-diabetic kidney disease already taking a maximum-dose ACE inhibitor, a low-sodium diet cut protein in the urine by about half, more than adding a second blood-pressure drug did.¹⁰

Potassium and phosphorus — Both matter more as CKD advances, and the right limits depend on your blood tests, so work them out with a renal dietitian. Processed foods deserve extra care: the body absorbs less than 40 percent of the phosphorus in plant foods but more than 80 percent of the phosphate added to processed foods as preservatives.¹¹

Medications That Protect Kidneys and Extend Healthspan

SGLT2 inhibitors (dapagliflozin, empagliflozin) — After the trial results above, KDIGO now recommends them for adults with CKD and an eGFR of at least 20 who have a urine albumin-to-creatinine ratio of 200 mg/g or more, or heart failure, and suggests them for people with an eGFR of 20 to 45 and less albuminuria.⁷

ACE inhibitors or ARBs — These lower pressure inside the kidney's filters and reduce albuminuria. KDIGO recommends starting one in people without diabetes who have high blood pressure, CKD and severely increased albuminuria.¹² Expect your doctor to recheck potassium and creatinine after starting one or changing the dose.

Blood pressure target: KDIGO suggests a systolic target below 120 mm Hg for adults with high blood pressure and CKD, when tolerated, using standardized office measurement. Home readings complement office readings between visits.¹²

Finerenone (Kerendia) — A non-steroidal mineralocorticoid receptor antagonist for people with CKD and type 2 diabetes. In FIDELIO-DKD it lowered the risk of kidney disease progression by 18 percent, and in FIGARO-DKD it lowered a composite of cardiovascular events by 13 percent. The notable side effect was high potassium.^13,14

Review medicines and supplements: KDIGO lists NSAID painkillers, such as ibuprofen and naproxen, among common medicines with documented kidney toxicity, so ask before using them regularly.⁷ Proton pump inhibitors have been linked to a higher risk of developing CKD in observational studies, about 50 percent higher in one large cohort, though that design cannot prove cause.¹⁵ Creatine has not been studied well in CKD; a 2019 meta-analysis found no kidney damage at the doses and durations studied, but ask your nephrologist first.¹⁶ If you need a contrast scan, tell the imaging team you have CKD.

Testing and Monitoring for CKD Longevity

eGFR and urine albumin (UACR) — The two numbers that define and stage CKD. eGFR measures filtering capacity; UACR detects kidney damage, often before eGFR falls. KDIGO ties how often to test to both numbers together, from once a year at lower risk to four or more times a year at the highest risk.⁷ The trend over time tells you more than any single value.

Cystatin C — Creatinine-based eGFR can mislead in people with unusually high or low muscle mass. In the 2021 CKD-EPI study, equations combining creatinine and cystatin C were more accurate than creatinine alone, so ask for a combined eGFR if your result doesn't fit the clinical picture.^7,17

Cholesterol and heart risk — Because CKD raises cardiovascular risk so sharply, cholesterol treatment matters. In the SHARP trial in people with moderate-to-severe CKD, simvastatin plus ezetimibe reduced major atherosclerotic events by 17 percent.¹⁸ Ask whether a statin is right for you, and keep blood pressure on target.

Vitamin D — The kidneys convert vitamin D into its active form, and that conversion falls as CKD advances. Prescription activated vitamin D (calcitriol and its analogs) is no longer used routinely in CKD stages G3a–G5 before dialysis; KDIGO reserves it for severe, progressive parathyroid hormone excess in stages G4–G5.¹⁹ Don't self-treat with high doses.

Hemoglobin and iron — CKD reduces erythropoietin production, and iron deficiency often adds to the anemia that follows, so hemoglobin, ferritin and transferrin saturation are worth tracking. Treatment targets are set individually: in the TREAT trial in people with diabetes and CKD, raising hemoglobin toward normal with darbepoetin did not reduce deaths or cardiovascular events and nearly doubled the risk of stroke.²⁰